Clinical Trials

Showing trials with last updates posted in 2024.

NCT06584578 | ACTIVE_NOT_RECRUITING | NA
400 participants

Exercise Nutrition and Body Composition

Study Type:
INTERVENTIONAL
Last Updated:
2024-09-05
Start Date:
2023-06-15
Completion:
2025-12-31
Conditions
  • Obesity
  • Overweight
  • Weight Loss
  • Muscle Maintenance
Interventions
  • OTHER
No Results Yet
NCT06577376 | NOT_YET_RECRUITING | PHASE1/PHASE2
252 participants

A PhaseⅠ/Ⅱ Study of Simmitinib or Irinotecan Liposomes Combined With DP303c in Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma

Study Type:
INTERVENTIONAL
Last Updated:
2024-09-05
Start Date:
2024-08-26
Completion:
2026-08-26
Conditions
  • Localized Advanced or Metastatic Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma
  • Expressing Human Epidermal Growth Factor Receptor-2 (HER-2)
  • Disease Progression After Receiving at Least One and at Most Two Lines of Systemic Treatment in the Past
Interventions
  • DRUG
No Results Yet
NCT06532253 | RECRUITING | PHASE1/PHASE2
15 participants

Long-term Safety Trial with NVDX3

Study Type:
INTERVENTIONAL
Last Updated:
2024-09-05
Start Date:
2024-08-22
Completion:
2036-03-31
Conditions
  • Distal Radius Fractures
  • Degenerative Lumbar Spondylolisthesis
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page